PhaseBio Pharmaceuticals, Inc. (PHAS)

Total Current Liabilities

$24.68M

Quarterly · Period ending: · USD

PHAS logo

PHAS Total Current Liabilities

Latest reported$27.88M
PHAS FY Current Liabilities ($844.00K → $27.88M)
High-resolution chart · PNG

PHAS total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)
27,883,000
14,960,000
8,479,000
4,577,000
17,595,000
844,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.